‌

US Patent 8034565 Gene expression markers for breast cancer prognosis

Patent 8034565 was granted and assigned to Genomic Health on October, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Genomic Health

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8034565

Patent Inventor Names

Steven Shak0

Joffre B. Baker0

Maureen T. Cronin0

Melody A. Cobleigh0

Date of Patent

October 11, 2011

Patent Application Number

12478632

Date Filed

June 4, 2009

Patent Citations Received

‌

US Patent 11776661 Determination of MAPK-AP-1 pathway activity using unique combination of target genes

‌

US Patent 12125561 Determination of JAK-STAT3 pathway activity using unique combination of target genes

Patent Primary Examiner

‌

Christopher M Babic

Patent abstract

The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8034565 Gene expression markers for breast cancer prognosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API